Værdipapirfonden Sparindex
16.10.2026 13:32:02 CEST | Globenewswire | Press release
Værdipapirfonden Sparinvest - ophævelse af suspension
Værdipapirfonden Sparinvest - ophævelse af suspension
Det skal oplyses, at suspension af nedenstående afdelinger nu er ophævet, hvorfor det igen er muligt at handle i afdelingerne.
Der er tale om følgende afdelinger:
| Fund Name | ISIN | Order Book Code |
| INDEX Bæredygtige Virksomhedsobligationer HY KL | DK0016028020 | SPVBVO |
| INDEX Emerging Market Bonds Lokalvaluta | DK0060254043 | SPVINO |
| INDEX Emerging Market Bonds Lokalvaluta Akk. - KL A | DK0060254126 | SPVINOAKKKLA |
| INDEX Globale Aktier KL | DK0060747822 | SPVIGAKL |
| INDEX Globale Aktier Min. Risiko Akk. KL | DK0060748127 | SPVIGAMRAKL |
| INDEX Bæredygtige Global KL | DK0060747905 | SPVIBGKL |
| INDEX Bæredygtige USA KL | DK0060748200 | SPVBUSAKL |
| INDEX Bæredygtige Europa KL | DK0060748044 | SPVBEUKL |
| INDEX Lav Risiko KL | DK0060748556 | SPVILRKL |
| INDEX Mellem Risiko KL | DK0060748630 | SPVIMRKL |
| INDEX Høj Risiko KL | DK0060748713 | SPVIHRKL |
| INDEX Emerging Market Bonds | DK0062729406 | SPVIEB |
| INDEX Emerging Market Bonds Akk. KL A | DK0062729596 | SPVIMA |
Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til npa.pm@nykredit.dk eller CRH@nykredit.dk.
Med venlig hilsen
Dirk Schulze
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom